-The Indian Express Public and private efforts must converge to battle it. With two decades of high economic growth, India should have been on its way to controlling tuberculosis. Yet it remains an urgent public health problem. With 1,000 Indians dying every day of TB, and with the highest number of TB patients in the world, India is undoubtedly the crucial battleground for TB control. The enhanced detection of drug-resistant TB has...

-The Indian Express Raised budgets are no guarantee of improved healthcare. With a new government in the offing, all suggested agendas for health are talking of an increase in health budgets and the fact that at 1 per cent of the GDP, government spending on public health in India is one of the lowest in the world; the rest is out of pocket expenditure. The US is a prime example of the...

-The Business Standard The Congress party's suggested right to health, if implemented, would be a game-changer This is the season for party manifestos with their vague and quite unexciting promises. But in this sea of platitudes, sometimes something stands out that is worth talking about, because, if implemented, it would be a game-changer. For me this is the reported inclusion of the right to health in the Congress party's manifesto. It is well...

-Live Mint Mint examines why millions of women are missing from farms, factories, colleges, and offices in India, which has one of the lowest ratios of working women in the world Mumbai: Every monsoon, minivans ferrying women labourers can be seen making their way from the small sleepy town of Wardha to Waifad village, 18 kilometres away. Urban workers from Wardha have come to occupy an integral part of Waifad's farm...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...